Cargando…
Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was develope...
Autores principales: | Wang, Ying, Yang, Chen, Song, Yutong, Coleman, J. Robert, Stawowczyk, Marcin, Tafrova, Juliana, Tasker, Sybil, Boltz, David, Baker, Robert, Garcia, Liliana, Seale, Olivia, Kushnir, Anna, Wimmer, Eckard, Mueller, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307828/ https://www.ncbi.nlm.nih.gov/pubmed/34193524 http://dx.doi.org/10.1073/pnas.2102775118 |
Ejemplares similares
-
577. COVI-VAC™, a Live Attenuated COVID-19 Vaccine, Provides Single Dose Protection Against Heterologous Challenge with SARS-CoV-2 Beta (B.1.351) in the Syrian Golden Hamster Model
por: Kushnir, Anna, et al.
Publicado: (2021) -
584. Phase 1 Placebo-Controlled Trial of COVI-VAC™, an Intranasal, Live Attenuated COVID-19 Vaccine
por: Tasker, Sybil, et al.
Publicado: (2021) -
Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets
por: Stauft, Charles B., et al.
Publicado: (2019) -
Putting Synthesis into Biology: A Viral View of Genetic Engineering through De Novo Gene and Genome Synthesis
por: Mueller, Steffen, et al.
Publicado: (2009) -
Antroquinonol A: Scalable Synthesis and Preclinical
Biology of a
Phase 2 Drug Candidate
por: Villaume, Matthew T., et al.
Publicado: (2015)